Target intelligence / Profile preview

Stool–mucus interface

Molecular classification
Other
01

Overview

The stool–mucus interface represents the complex physiological boundary in the large intestine where the fecal stream meets the protective mucus layer covering the intestinal epithelium. This interface is characterized by a gradient of oxygen, nutrients, and microbial density, serving as a critical selective barrier that facilitates nutrient absorption while sequestering the dense gut microbiota away from the host's epithelial cells (Johansson et al., 2011, Nature Reviews Gastroenterology & Hepatology). The primary structural component of this interface is the gel-forming mucin MUC2, which forms a dense, inner stratified layer that is normally devoid of bacteria and a loose outer layer where host-microbe interactions occur (Hansson, 2020, Science Immunology). In pathological states such as ulcerative colitis, the integrity of this interface is compromised, leading to direct contact between fecal bacteria and the epithelium, which triggers chronic inflammation. While the stool–mucus interface is not a single molecular target, it is a major focus in pharmacology and biotechnology for the development of mucus-penetrating or mucoadhesive drug delivery systems designed to optimize the local or systemic delivery of therapeutics (Ensign et al., 2012, Advanced Drug Delivery Reviews).

Other names
Fecal-mucus interfaceIntestinal mucus barrierColonic mucus-stool interfaceMucus-microbiota interface
02

Mechanism of action

Not applicable as this is a physiological interface/microenvironment rather than a specific molecular target.

03

Biological functions

Barrier functionMicrobiome-host interactionPathogen exclusionLubricationSelective permeability
04

Disease associations

Inflammatory bowel diseaseColorectal cancerInfectionIrritable bowel syndromeCystic fibrosis
05

Safety considerations

Mucus layer degradationIncreased epithelial permeability (Leaky gut)Bacterial translocationMucoadhesion-related toxicity
06

Biomarkers

Fecal calprotectinMUC2 mucin levelsMucus layer thicknessFecal microbiota diversity

Beyond the preview

Go deeper on Stool–mucus interface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stool–mucus interface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call